Diabetes-associated variation in TCF7L2 is not associated with hepatic or extrahepatic insulin resistance

Diabetes

Volumn 65, Issue 4, 2016, Pages 887-892

  Varghese, Ron T ^a   Viegas, Ivan ^b   Barosa, Cristina ^b   Marques, Catia ^b   Shah, Meera ^a   Rizza, Robert A ^a   Jones, John G ^b   Vella, Adrian ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCAGON; GLUCOSE; INSULIN; TRANSALDOLASE; TRANSCRIPTION FACTOR 7 LIKE 2; TCF7L2 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CLINICAL ARTICLE; DIABETES MELLITUS; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; GLUCONEOGENESIS; GLYCOGENOLYSIS; HUMAN; INSULIN RESISTANCE; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; CASE CONTROL STUDY; GENETIC ASSOCIATION STUDY; GENETICS; GLUCOSE CLAMP TECHNIQUE; LIVER; METABOLISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; LIVER; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 84962160951     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-1593     Document Type: Article

References (21)

1. Florez JC, Jablonski KA, Bayley N, et al; Diabetes Prevention Program Research Group. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 2006; 355:241-250
2. Elbein SC, Chu WS, Das S.K., et al. Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent. Diabetologia 2007; 50:1621-1630
3. Wegner L, Hussain MS, Pilgaard K, et al Impact of TCF7L2 rs7903146 on insulin secretion and action in young and elderly Danish twins. J Clin Endocrinol Metab 2008; 93:4013-4019
4. Liu PH, Chang YC, Jiang Y.D., et al. Genetic variants of TCF7L2 are associated with insulin resistance and related metabolic phenotypes in Taiwanese adolescents and Caucasian young adults. J Clin Endocrinol Metab 2009; 94:3575-3582
5. Pilgaard K, Jensen CB, Schou J.H., et al. The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men. Diabetologia 2009; 52:1298-1307
6. Bock G, Dalla Man C, Campioni M, et al Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 2006; 55:3536-3549
7. Meyer C, Pimenta W, Woerle H.J., et al. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 2006; 29:1909-1914
8. Rasmussen-Torvik L.J., Pankow JS, Jacobs DR Jr, Sinaiko AR. Preliminary report: no association between TCF7L2 rs7903146 and euglycemic-clamp-derived insulin sensitivity in a mixed-age cohort. Metabolism 2009; 58:1369-1371
9. Lyssenko V, Lupi R, Marchetti P., et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007; 117:2155-2163
10. Mulholland DJ, Dedhar S, Coetzee G.A., Nelson CC. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Endocr Rev 2005; 26:898-915
11. Zhao J, Schug J, Li M., Kaestner KH, Grant SF. Disease-associated loci are significantly over-represented among genes bound by transcription factor 7-like 2 (TCF7L2) in vivo. Diabetologia 2010; 53:2340-2346
12. Norton L, Fourcaudot M, Abdul-Ghani MA, et al. Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism. Diabetologia 2011; 54:3132-3142
13. Bock G, Chittilapilly E, Basu R., et al. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis. Diabetes 2007; 56:1703-1711
14. Shah M, Varghese RT, Miles J.M., et al. TCF7L2 genotype and α-cell function in humans without diabetes. Diabetes 2016; 65:371-380
15. 13C-enrichment of human glucuronide from metabolic tracers. J Carbohydr Chem 2006; 25:203-217
16. 2O to measure gluconeogenesis in humans. Diabetes 2008; 57:50-55
17. Basu R, Barosa C, Basu A., et al. Transaldolase exchange and its effects on measurements of gluconeogenesis in humans. Am J Physiol Endocrinol Metab 2011; 300:E296-E303
18. Steele R, Wall JS, De Bodo RC, Altszuler N. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 1956; 187:15-24
19. Smushkin G, Sathananthan M, Sathananthan A., et al. Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1. Diabetes 2012; 61:1082-1089
20. Daniele G, Gaggini M, Comassi M., et al. Glucose metabolism in high-risk subjects for type 2 diabetes carrying the rs7903146 TCF7L2 gene variant. J Clin Endocrinol Metab 2015; 100:E1160-E1167
21. Vella A, Rizza RA Application of isotopic techniques using constant specific activity or enrichment to the study of carbohydrate metabolism. Diabetes 2009; 58:2168-2174